National and Kapodistrian University of Athens
Μοριακός φαινότυπος των καρκινωμάτων της ανώτερης αποχετευτικής μοίρας του ουροποιητικού συστήματος
Abstract
dc:descriptionUpper Urinary Tract Tumors (renal pelvis and ureter) represent arare disease, not well studied. They come from the transitional epitheliumand account only for 5% of all urothelial carcinomas. Tumor stage andgrade are the only established prognostic factors. The aggressive nature,however, of this tumor along with the unpredictable, usually, clinicalcourse, render the identification of novel therapeutic approaches ratheressential. The ErbB family receptors are a field for research of highinterest and targeted therapies are already being used for other types ofcancer. This study aimed to correlate ErbB2, ErbB3 and ErbB4expression in Upper Urinary Tract Urothelial Carcinoma (UUTUC) withother clinicopathological parameters as well as patient outcome. ErbB2, ErbB3 and ErbB4 were immunohistochemically assessed in99 consecutive UUTUC specimens. All statistical analyses wereperformed using the SPSS statistical program, version 16. Overall, 28,3% of patients died during the follow-up of 127months, 1-95 months after the first surgical treatment and mean survivalwas 18,9±24,2 months. ErbB2, ErbB3 and ErbB4 expression was presentin 64,8%, 19,5%, and 20,8% of tumors, respectively. Combinedexpression of all three receptors was found in 7,9% of the tumors,combined expression of two receptors in 14,5% and 48,7% expressed atleast one ErbB receptor. No ErbB expression was found in 28,9% oftumors. We found no significant correlation between ErbB2, ErbB3 andErbB4 expression with tumor stage, grade, recurrence or cancer specificsurvival apart from the inverse relation between ErbB2 expression andtime to recurrence (p=0.027). In conclusion, of the three receptors we evaluated, neither ErbB3nor ErbB4 have any prognostic significance in the UUTUC. ErbB2, however, is inversely related to recurrence and, although this is notenough to justify the introduction of anti-ErbB treatment in everydayclinical practice, it needs further evaluation in well designed, prospective,randomized trials.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Galanakis, Ioannis
- Γαλανάκης, Ιωάννης
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/41255